EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1
EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1
In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019
This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 18 apríla 2024. Database contains 4917 unique substances/entries.
Filter the list
|
AROCY M-10
|
405-790-4
|
101657-77-6
|
Skin Sens. 1 |
Details | ||
|
243-420-1
|
19900-65-3
|
Carc. 2; Acute Tox. 4 |
Details | |||
|
LONZACURE M-MIPA
|
415-150-6
|
16298-38-7
|
STOT RE 2 |
Details | ||
|
LUPRAGEN VP 9199 X
|
412-840-9
|
13474-64-1
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1A |
Details | ||
|
225-863-2
|
5124-30-1
|
Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
212-658-8
|
838-88-0
|
Carc. 1B; Acute Tox. 4; Skin Sens. 1 |
C Carcinogenic (article 57a) |
Details | ||
|
202-966-0
|
101-68-8
|
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
431-850-4
|
7456-68-0
|
Expl. 1.1; STOT RE 2 |
Details | |||
|
DD-63
|
404-590-4
|
90884-29-0
|
Skin Sens. 1 |
Details | ||
|
201-286-1
|
80-51-3
|
Self-react. D |
Details | |||
|
202-977-0
|
101-80-4
|
C Carcinogenic (article 57a) M Mutagen (article 57b) |
Details | |||
|
show/hide
|
-
|
-
|
Carc. 1B; Muta. 1B; Repr. 2; Acute Tox. 3 |
Details | ||
|
201-250-5
|
80-09-1
|
Repr. 1B |
R Toxic for reproduction (article 57c) END Endocrine disrupting properties (Article 57(f) - human health) ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
HMPSC
|
403-330-7
|
24197-34-0
|
Eye Dam. 1 |
Details | ||
|
205-370-9
|
139-65-1
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
421-360-9
|
148043-73-6
|
Acute Tox. 4 |
Details | |||
|
CARBONATE DE TETRACHLOROETHYLENE
|
404-060-2
|
22432-68-4
|
Acute Tox. 2; Acute Tox. 4; Skin Corr. 1B |
Details | ||
|
AMINOBUTYRALDEHYDE DIMETHYL ACETAL
|
407-690-6
|
19060-15-2
|
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
Details | ||
|
TRIOXABICYCLOOCTAN; TRIOXABICYCLOOCTANE
|
421-750-9
|
57280-22-5
|
Eye Irrit. 2; Skin Sens. 1 |
Details | ||
|
AP-5
|
401-720-1
|
6807-17-6
|
Repr. 1B; Eye Irrit. 2 |
R Toxic for reproduction (article 57c) |
Details | |
|
264-843-8
|
64359-81-5
|
Acute Tox. 2; Acute Tox. 4; Skin Corr. 1; Eye Dam. 1; Skin Sens. 1A |
Details | |||
|
HOMOFARNESYLSÄURE
|
403-000-2
|
91853-67-7
|
Skin Irrit. 2 |
Details | ||
|
ORRINIFF
|
402-520-7
|
125352-06-9
|
Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1 |
Details | ||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
621-341-7
|
2315-61-9
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
205-426-2
|
140-66-9
|
Skin Irrit. 2; Eye Dam. 1 |
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
|
423-860-2
|
56309-94-5
|
Skin Sens. 1 |
Details | |||
|
257-907-1
|
52427-13-1
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
ACRYLOYLMORPHOLIN
|
418-140-1
|
5117-12-4
|
Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
635-388-6
|
521947-27-3
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
WL 125892
|
402-190-4
|
113674-95-6
|
STOT RE 1; Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
LICHTSCHUTZMITTEL 1071
|
413-510-7
|
147374-67-2
|
STOT RE 2; Skin Sens. 1 |
Details | ||
|
4-ALLYLOXYBENZOESÄURE-(4-METHACRYLOYL)PHENYLESTER
|
429-000-2
|
159235-16-2
|
Skin Sens. 1 |
Details | ||
|
-
|
-
|
R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
272-233-8
|
68784-25-8
|
R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
MORTRACE ST CONC.
|
410-600-8
|
124719-26-2
|
STOT RE 2; Skin Irrit. 2 |
Details | ||
|
635-389-1
|
186825-36-5
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
635-391-2
|
142731-63-3
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
635-696-0
|
186825-39-8
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
CARBODIM
|
413-120-7
|
107144-30-9
|
Acute Tox. 4 |
Details | ||
|
210-322-5
|
612-82-8
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
277-985-0
|
74753-18-7
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
208-519-6
|
531-85-1
|
Carc. 1A; Acute Tox. 4 |
Details | |||
|
208-520-1
|
531-86-2
|
Carc. 1A; Acute Tox. 4 |
Details | |||
|
250-863-4
|
31906-04-4
|
Skin Sens. 1A |
Details | |||
|
MORTRACE SB CONC.
|
410-610-2
|
111850-24-9
|
STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
Details | ||
|
JKY-120
|
405-730-7
|
51601-57-1
|
STOT RE 2 |
Details | ||
|
426-900-7
|
203118-12-1
|
STOT SE 3 |
Details | |||
|
431-200-1
|
208538-34-5
|
Acute Tox. 4; Eye Dam. 1; Skin Sens. 1 |
Details | |||
|
4-(4-PROPYLCYCLOHEXYL)-ACETOPHENON
|
406-700-6
|
78531-61-0
|
Skin Sens. 1 |
Details | ||